Improving interMediAte Risk management. MARK study

BMC Cardiovascular Disorders

Volumn 11, Issue , 2011, Pages

  Martí, Ruth ^a,b   Parramon, Dídac ^a,b   García Ortiz, Luís ^c   Rigo, Fernando ^d   Gómez Marcos, Manuel A ^c   Sempere, Irene ^d   García Regalado, Natividad ^d   Recio Rodriguez, Jose I ^c   Agudo Conde, Cristina ^c   Feuerbach, Natalia ^d   Garcia Gil, Maria ^a,e   Ponjoan, Anna ^a,b   Quesada, Miquel ^a,b,e   Ramos, Rafel ^a,b,e  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^c Biomedical Research Institute of Salamanca IBSAL   (Spain)

^d Gerencia Atención Primaria Ibsalut ^*  (Spain)

^e UNIVERSITY OF GIRONA   (Spain)

Author keywords

Cardiovascular diseases; Primary health care; Primary prevention; Risk assessment

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ANTHROPOMETRIC PARAMETERS; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIETARY INTAKE; EXERCISE INTENSITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE POLICY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; PULSE WAVE; QUANTITATIVE STUDY; RISK ASSESSMENT; RISK FACTOR; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SPAIN; SURVIVAL;

ADULT; AGED; ANKLE BRACHIAL INDEX; BLOOD GLUCOSE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ADJUSTMENT; RISK ASSESSMENT; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS;

EID: 80053908085     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-11-61     Document Type: Article

References (34)

1. Mortality study in Spain. Instituto de Salud Carlos III (08/01/2010). , http://193.146.50.130/raziel.php
2. Marrugat J, Elosua R, Martí H. Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005. Rev Esp Cardiol 2002, 55:337-346.
3. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007, 28:2375-414.
4. Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, Nam BH, Ramos R, Sala J, Solanas P, Cordón F, Gené-Badia J, D'Agostino RB, . VERIFICA Investigators Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study. J Epidemiol Community Health 2007, 61:40-47. 10.1136/jech.2005.038505, 2465597, 17183014, VERIFICA Investigators.
5. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, Boerwinkle E, Mosley TH, Sorlie P, Diao G, Sharrett AR. An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk Markers. Arch Intern Med 2006, 166:1368-73. 10.1001/archinte.166.13.1368, 16832001.
6. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 151:496-507.
7. U.S. Preventive Services Task Force Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151:474-482. U.S. Preventive Services Task Force.
8. Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007, 115:949-952. 10.1161/CIRCULATIONAHA.106.683110, 17325253.
9. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Fowkes FG, Lee AJ, Price JF, d'Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodríguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, McDermott MM, Stoffers HE, Hooi JD, Knottnerus JA, Ogren M, Hedblad B, Witteman JC, Breteler MM, Hunink MG, Hofman A, Criqui MH, Langer RD, Fronek A, Hiatt WR, Hamman R, Resnick HE, Guralnik J, McDermott MM. Ankle Brachial Index Collaboration Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300:197-208. 2932628, 18612117, Ankle Brachial Index Collaboration.
10. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ, . German Epidemiological Trial on Ankle Brachial Index Study Group Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009, 120:2053-2061. 10.1161/CIRCULATIONAHA.109.865600, 19901192, German Epidemiological Trial on Ankle Brachial Index Study Group.
11. Ramos R, Quesada M, Solanas P, Subirana I, Sala J, Vila J, Masiá R, Cerezo C, Elosua R, Grau M, Cordón F, Juvinyà D, Fitó M, Isabel Covas M, Clarà A, Angel Muñoz M, Marrugat J, . REGICOR Investigators Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg 2009, 38:305-311. 10.1016/j.ejvs.2009.04.013, 19515589, REGICOR Investigators.
12. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis. J Am Coll Cardiol 2010, 55:1318-1327. 10.1016/j.jacc.2009.10.061, 20338492.
13. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A, . European Society of Hypertension Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009, 27:2121-58. 10.1097/HJH.0b013e328333146d, 19838131, European Society of Hypertension.
14. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006, 13:101-107. 10.5551/jat.13.101, 16733298.
15. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, Matsuda S, Miyazaki Y, Hiratsuka A, Matsuzaki M. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res 2008, 31:1347-1355. 10.1291/hypres.31.1347, 18957805.
16. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141:421-431.
17. Adams RJ, Appleton SL, Hill CL, Wilson DH, Taylor AW, Chittleborough CR, Gill TK, Ruffin RE. Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes. Obesity (Silver Spring) 2009, 17:559-563.
18. Selvin E, Zhu H, Brancati FL. Elevated A1C in Adults Without a History of Diabetes in the U.S. Diabetes Care 2009, 32:828-833. 10.2337/dc08-1699, 2671106, 19196895.
19. Bonora E. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives. Int J Clin Pract Suppl 2002, 129:5-11.
20. Peter R, Okoseime OE, Rees A, Owens DR. Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortality. Curr Vasc Pharmacol 2009, 7:68-74. 10.2174/157016109787354169, 19149642.
21. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Kikuya M, Ito S, Satoh H, Hisamichi S. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998, 16:971-975. 10.1097/00004872-199816070-00010, 9794737.
22. Soriano JB, Rigo F, Guerrero D, Yañez A, Forteza JF, Frontera G, Togores B, Agustí A. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest 2010, 137:333-40. 10.1378/chest.09-1264, 19783666.
23. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008, 336:1475-82. 10.1136/bmj.39609.449676.25, 2440904, 18573856.
24. Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2000, 160:1761-8. 10.1001/archinte.160.12.1761, 10871968.
25. Sachdev M, Sun JL, Tsiatis AA, Nelson CL, Mark DB, Jollis JG. The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol 2004, 43:576-82. 10.1016/j.jacc.2003.10.031, 14975466.
26. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, Solanas P, Cordón F, Ramos R, Sala J, Masiá R, Kannel WB. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003, 57:634-638. 10.1136/jech.57.8.634, 1732543, 12883073.
27. Conroya RM, Pyoralab K, Fitzgeralda AP, Sansc S, Menottid A, De Backere G, De Bacquere D, Ducimetie'ref P, Jousilahtig P, Keilh U, Njølstadi I, Oganovj RG, Thomsenk T, Tunstall-Pedoel H, Tverdalm A, Wedeln H, Whincupo P, Wilhelmsenn L, Grahama IM, . on behalf of the SCORE project group Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 2003, 24:987-1003. 10.1016/S0195-668X(03)00114-3, 12788299, on behalf of the SCORE project group.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
29. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968, 16:622-626.
30. Schröder H, Covas MI, Marrugat J, Vila J, Pena A, Alcántara M, Masiá R. Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr 2001, 20:429-437. 10.1054/clnu.2001.0460, 11534938.
31. Mártinez-González MA, Fernández-Jarne E, Serrano-Martínez M, Wright M, Gomez-Garcia E. Development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet. Eur J Clin Nutr 2004, 58:1550-1552. 10.1038/sj.ejcn.1602004, 15162136.
32. Elosua R, Marrugat J, Molina L, Pons S, Pujol E. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM investigators. Am J Epidemiol 1994, 139:1197-1209.
33. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992, 45:1101-1109. 10.1016/0895-4356(92)90150-L, 1474406.
34. Stergiu GS, Skeva II, Zourbaki AS, Mountokalakis TD. Self-monitoring of blood pressure at home: how many measurements are needed?. J Hypertens 1998, 16:725-31. 10.1097/00004872-199816060-00002, 9663911.